Noteworthy, we found a significant reduction in the number of infiltrating CD20+ B cells in T3 and T4 tumors compared with smaller cancer sizes, which suggests that the reduction in the tumoral B lymphocyte infiltration could be associated with tumor progression. This evidence concerns the gene MS4A1 and neoplasm.